LTFS
BIO icon

Ladenburg Thalmann Financial Services’s Bio-Rad Laboratories Class A BIO Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$733K Buy
1,968
+28
+1% +$9.87K ﹤0.01% 1511
2019
Q3 		$647K Buy
1,940
+521
+37% +$170K ﹤0.01% 1558
2019
Q2 		$441K Sell
1,419
-27
-2% -$8.09K ﹤0.01% 1848
2019
Q1 		$443K Sell
1,446
-203
-12% -$54.8K ﹤0.01% 1780
2018
Q4 		$374K Buy
1,649
+1,195
+263% +$321K ﹤0.01% 1756
2018
Q3 		$140K Sell
454
-510
-53% -$158K ﹤0.01% 2581
2018
Q2 		$240K Hold
964
– – ﹤0.01% 2093
2018
Q1 		$240K Buy
964
+12
+1% +$3.06K ﹤0.01% 2093
2017
Q4 		$228K Sell
952
-51
-5% -$12.4K ﹤0.01% 2115
2017
Q3 		$223K Sell
1,003
-121
-11% -$27.2K ﹤0.01% 2019
2017
Q2 		$254K Buy
1,124
+267
+31% +$58.2K ﹤0.01% 1848
2017
Q1 		$171K Sell
857
-163
-16% -$31.4K ﹤0.01% 2028
2016
Q4 		$176K Buy
1,020
+65
+7% +$11.1K ﹤0.01% 1906
2016
Q3 		$156K Buy
955
+502
+111% +$76.2K ﹤0.01% 1922
2016
Q2 		$65K Buy
453
+12
+3% +$1.71K ﹤0.01% 2477
2016
Q1 		$61K Buy
441
+13
+3% +$1.71K ﹤0.01% 2428
2015
Q4 		$59K Sell
428
-1
-0.2% -$139 ﹤0.01% 2442
2015
Q3 		$58K Buy
429
+5
+1% +$720 ﹤0.01% 2366
2015
Q2 		$63K Buy
424
+208
+96% +$29.8K ﹤0.01% 2423
2015
Q1 		$29K Sell
216
-18
-8% -$2.23K ﹤0.01% 2940
2014
Q4 		$28K Buy
234
+216
+1,200% +$24.9K ﹤0.01% 2755
2014
Q3 		$2K Hold
18
– – ﹤0.01% 3652
2014
Q2 		$2K Buy
18
+12
+200% +$1.47K ﹤0.01% 3615
2014
Q1 		$1K Hold
6
– – ﹤0.01% 3610
2013
Q4 		$1K Buy
6
+1
+20% +$122 ﹤0.01% 3605
2013
Q3 		$1K Hold
5
– – ﹤0.01% 3539
2013
Q2 		$1K Buy
+5
New +$587 ﹤0.01% 3437

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Ladenburg Thalmann Financial Services's BIO Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Bio-Rad Laboratories Class A (BIO) stake by 1.4% in Q4 2019, buying an estimated $9.87K and bringing the position to 1,968 shares worth $733K. The position accounts for ﹤0.01% of the portfolio, ranked #1511.

Ladenburg Thalmann Financial Services first reported a position in BIO in Q2 2013 and has held it in 27 quarters since. 386 funds tracked by Wall St. Rank hold BIO as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 1,968 shares of Bio-Rad Laboratories Class A worth $733K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 28 Bio-Rad Laboratories Class A shares in Q4 2019, an estimated $9.87K.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #1511 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 27 quarters since.
  • 386 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.